DRUG DESIGNATION: Pfizer says U.S. regulators have classified its experimental pill for advanced, often-deadly breast cancer as a breakthrough therapy. That's done to speed up development and review of treatments seen as big advances.
THE RESEARCH: Palbociclib is in late-stage testing as an initial treatment for the biggest subgroup of postmenopausal women with advanced breast cancer — those in whom tumor growth is fueled by the hormone estrogen but not by a growth-promoting protein called HER2.
MORE TESTING: Pfizer, which has made research on cancer medicines a priority, also is testing palbociclib as a treatment for other cancers.
“Walking Dead” mid-season finale grumble thread: So many grumbles
Peter Morici - 2015 Paris Climate Conference: Another Bad Deal for America
How a Local Crime Story about Workplace Violence Becomes National News | RedState
A Resurgence of Intolerance
NRA Thanks Obama For Signing Pro-Gun Legislation - Bearing Arms - Barack Obama, National Defense Authorization Act
George Soros: Top 10 Reasons He Is Dangerous | Human Events
CBS News calls Planned Parenthood videos 'now discredited'